The Cupertino-based company has developed an endometrial ablation system utilizing RF Argon Plasma Energy contained in a balloon to treat heavy menstrual bleeding.
Based on a search of the U.S. Securities and Exchange Commission’s Edgar database, the company has been steadily raising money since 2008 and has raised more than $55 million. David M. Clapper, a 16-year veteran of Johnson & Johnson, is Minerva Surgical’s CEO.
Venture capital firm New Enterprise Associates and Vivo Ventures are investors in the company, although it is not known whether they invested in this round of funding.
[Photo Credit: Pile of Money from Big Stock Photo]